Why the study?
Does a single dose of acetylsalicylic acid improve haemopoietic status by decreasing neocytolysis in patients with Type 2 diabetes mellitus and/or chronic renal failure?
Population
55 subjects total: patients with Type 2 diabetes mellitus, patients with DM and chronic renal failure…
Comparison
Single dose of 1 gram acetylsalicylic acid (ASA) vs Non-diabetic, nonazotemic control subjects and…
Design
Cross-sectional
Authors
Loading...
May support ASA for anemia in T2DM/CRF; hypothesis-generating from Level 4 data and requires RCTs before practice change.
Does a single dose of acetylsalicylic acid improve haemopoietic status by decreasing neocytolysis in patients with Type 2 diabetes mellitus and/or chronic renal failure?
A single dose of acetylsalicylic acid may ameliorate anaemia in patients with diabetes and/or chronic renal failure by increasing serum erythropoietin levels and decreasing neocytolysis.
Wittmann et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: